---
title: BioVectra vs FUJIFILM Biotechnologies
slug_a: biovectra
slug_b: fujifilm-biotechnologies
site: cdmo
review_signal_gate: closed
canonical_path: /compare/biovectra/fujifilm-biotechnologies
---

# BioVectra vs FUJIFILM Biotechnologies

Side-by-side profile data from each company listing on this directory.

## BioVectra

- Profile: [/companies/biovectra](/companies/biovectra)

BioVectra — North American CDMO specializing in clinical-to-commercial biologics, small molecules, HPAPIs, and bioreagents with 50+ years of microbial fermentation and complex chemistry expertise across cGMP facilities in Canada.

Services: 16. Modalities: 5. Indications: 0. Locations: 9. Certifications: 0. The strongest documented coverage currently appears in services (16).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- HPAPI Manufacturing (High-Potency)
- Biologics Development & Manufacturing
- Recombinant Protein Manufacturing
- Cell-Line Development
- Upstream Processing
- Downstream Processing
- Microbial Fermentation
- mRNA Manufacturing
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- CMC Regulatory Submission Support

### Modalities

- Small Molecule
- Biologics (Other)
- Oligonucleotide
- mRNA
- Gene Therapy

### Development capabilities

- Analytical method development
- Formulation development
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Max bioreactor: Large commercial (≤10,000 L)
- Expression: Mammalian
- Expression: Microbial
- Expression: Viral Vector
- Expression: Cell-Free
- Stainless Steel
- Max chemical: Commercial (>100 kg / tonne)
- HPAPI
- Flow Chemistry

## FUJIFILM Biotechnologies

- Profile: [/companies/fujifilm-biotechnologies](/companies/fujifilm-biotechnologies)

FUJIFILM Biotechnologies — CDMO partner offering end-to-end biologics development and manufacturing from pre-clinical through commercialization, with expertise in cell culture, microbial fermentation, cell and gene therapy, and cGMP manufacturing across US and European facilities.

Services: 18. Modalities: 5. Indications: 0. Locations: 13. Certifications: 0. The strongest documented coverage currently appears in services (18).

### Services

- Biologics Development & Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- Cell-Line Development
- Upstream Processing
- Downstream Processing
- Microbial Fermentation
- Viral Vector Manufacturing
- Cell Therapy Manufacturing
- Vaccine Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- CMC Regulatory Submission Support

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Cell Therapy
- Gene Therapy
- Vaccine

### Development capabilities

- Analytical method development
- Formulation development
- ICH stability testing
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Expression: Mammalian
- Expression: Microbial
- Expression: Viral Vector
- Expression: Cell-Free
- Single-Use / Disposable
- Stainless Steel